These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36681087)

  • 1. Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study.
    Ghalwash M; Anand V; Lou O; Martin F; Rewers M; Ziegler AG; Toppari J; Hagopian WA; Veijola R;
    Lancet Child Adolesc Health; 2023 Apr; 7(4):261-268. PubMed ID: 36681087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study.
    Ghalwash M; Dunne JL; Lundgren M; Rewers M; Ziegler AG; Anand V; Toppari J; Veijola R; Hagopian W;
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):589-596. PubMed ID: 35803296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
    Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
    JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children.
    Ng K; Anand V; Stavropoulos H; Veijola R; Toppari J; Maziarz M; Lundgren M; Waugh K; Frohnert BI; Martin F; Lou O; Hagopian W; Achenbach P;
    Diabetologia; 2023 Jan; 66(1):93-104. PubMed ID: 36195673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
    Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.
    Ilonen J; Lempainen J; Hammais A; Laine AP; Härkönen T; Toppari J; Veijola R; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):284-292. PubMed ID: 28597949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies.
    Winkler C; Schober E; Ziegler AG; Holl RW
    Pediatr Diabetes; 2012 Jun; 13(4):308-13. PubMed ID: 22060727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany.
    Ziegler AG; Kick K; Bonifacio E; Haupt F; Hippich M; Dunstheimer D; Lang M; Laub O; Warncke K; Lange K; Assfalg R; Jolink M; Winkler C; Achenbach P;
    JAMA; 2020 Jan; 323(4):339-351. PubMed ID: 31990315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
    Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
    Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY).
    Barker JM; Barriga KJ; Yu L; Miao D; Erlich HA; Norris JM; Eisenbarth GS; Rewers M;
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3896-902. PubMed ID: 15292324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
    Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
    Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood Height Growth Rate Association With the Risk of Islet Autoimmunity and Development of Type 1 Diabetes.
    Li Z; Veijola R; Koski E; Anand V; Martin F; Waugh K; Hyöty H; Winkler C; Killian MB; Lundgren M; Ng K; Maziarz M; Toppari J
    J Clin Endocrinol Metab; 2022 May; 107(6):1520-1528. PubMed ID: 35244713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
    Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
    Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The measurement of autoantibodies to insulin informs diagnosis of diabetes in a childhood population negative for other autoantibodies.
    Williams CL; Aitken RJ; Wilson IV; Mortimer GLM; Long AE; Williams AJK; ; Gillespie KM
    Diabet Med; 2022 Dec; 39(12):e14979. PubMed ID: 36251483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
    Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
    Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children.
    Ng K; Stavropoulos H; Anand V; Veijola R; Toppari J; Maziarz M; Lundgren M; Waugh K; Frohnert BI; Martin F; Hagopian W; Achenbach P;
    Diabetes Care; 2022 Jan; 45(1):160-168. PubMed ID: 34758977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landmark models to define the age-adjusted risk of developing stage 1 type 1 diabetes across childhood and adolescence.
    Hoffmann VS; Weiß A; Winkler C; Knopff A; Jolink M; Bonifacio E; Ziegler AG
    BMC Med; 2019 Jul; 17(1):125. PubMed ID: 31286933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
    Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.